These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2084633)

  • 21. Emergence of resistance in gram-negative bacilli during beta-lactam therapy: a challenge for the future.
    Pechère JC
    Eur J Cancer Clin Oncol; 1989; 25 Suppl 2():S17-23. PubMed ID: 2693106
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Beta-lactam antibiotics].
    Suárez C; Gudiol F
    Enferm Infecc Microbiol Clin; 2009 Feb; 27(2):116-29. PubMed ID: 19254642
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Continuous infusion of beta-lactam antibiotics in severe infections: a review of its role.
    Roberts JA; Paratz J; Paratz E; Krueger WA; Lipman J
    Int J Antimicrob Agents; 2007 Jul; 30(1):11-8. PubMed ID: 17442541
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antibacterial chemotherapy. Part One. B-lactam antibiotics.
    Hansman D
    Aust Fam Physician; 1987 Nov; 16(11):1646-9. PubMed ID: 3328607
    [No Abstract]   [Full Text] [Related]  

  • 25. Beta-lactam therapy of osteomyelitis and septic arthritis.
    Wilber RB
    Scand J Infect Dis Suppl; 1984; 42():155-68. PubMed ID: 6396837
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Therapeutic drug monitoring of beta-lactams for critically ill patients: unwarranted or essential?
    Roberts JA; Hope WW; Lipman J
    Int J Antimicrob Agents; 2010 May; 35(5):419-20. PubMed ID: 20189777
    [No Abstract]   [Full Text] [Related]  

  • 27. Comparison of ciprofloxacin and beta-lactam antibiotics in the treatment of urinary tract infections and alteration of fecal flora.
    Daikos GL; Kathpalia SB; Sharifi R; Lolans VT; Jackson GG
    Am J Med; 1987 Apr; 82(4A):290-4. PubMed ID: 3555050
    [TBL] [Abstract][Full Text] [Related]  

  • 28. How beta-lactamases have driven pharmaceutical drug discovery. From mechanistic knowledge to clinical circumvention.
    Bush K; Mobashery S
    Adv Exp Med Biol; 1998; 456():71-98. PubMed ID: 10549364
    [No Abstract]   [Full Text] [Related]  

  • 29. [Re-evaluation of the gastrointestinal effects of beta-lactam inhibitors of beta-lactamase].
    Sábada B
    Rev Esp Quimioter; 1998 Dec; 11(4):377-9. PubMed ID: 10336322
    [No Abstract]   [Full Text] [Related]  

  • 30. Antibiotics for acute orofacial infections.
    Pallasch TJ
    J Calif Dent Assoc; 1993 Feb; 21(2):34-44. PubMed ID: 7693890
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Taking inventory: antibacterial agents currently at or beyond phase 1.
    Bush K; Macielag M; Weidner-Wells M
    Curr Opin Microbiol; 2004 Oct; 7(5):466-76. PubMed ID: 15451501
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Ertapenem].
    Gobernado M; Acuña C
    Rev Esp Quimioter; 2007 Sep; 20(3):277-99. PubMed ID: 18080025
    [No Abstract]   [Full Text] [Related]  

  • 33. The incidence of beta-lactamase-producing pathogens.
    Acar JF; Kitzis MD; Gutmann L
    APMIS Suppl; 1989; 5():2-8. PubMed ID: 2660867
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel plasmid-mediated beta-lactamases in enterobacteriaceae: emerging problems for new beta-lactam antibiotics.
    Thomson KS; Prevan AM; Sanders CC
    Curr Clin Top Infect Dis; 1996; 16():151-63. PubMed ID: 8714252
    [No Abstract]   [Full Text] [Related]  

  • 35. Evaluation and treatment of patients with prior reactions to beta-lactam antibiotics.
    Weiss ME
    Curr Clin Top Infect Dis; 1993; 13():131-45. PubMed ID: 8397906
    [No Abstract]   [Full Text] [Related]  

  • 36. Better and better beta-lactams.
    Ellis-Pegler RB
    N Z Med J; 1983 Apr; 96(729):243-5. PubMed ID: 6601249
    [No Abstract]   [Full Text] [Related]  

  • 37. Beta-lactam antibiotics: newer formulations and newer agents.
    Martin SI; Kaye KM
    Infect Dis Clin North Am; 2004 Sep; 18(3):603-19, ix. PubMed ID: 15308278
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Infectious morbidity in gynecologic oncology.
    Graham JE
    J Reprod Med; 1990 Mar; 35(3 Suppl):348-52. PubMed ID: 2181122
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Evaluation of sensitivity to antibiotics of microorganisms isolated from children with urinary tract infections].
    Cisowska A; Lewczyk E; Korzekwa K; Wojnicz D; Jankowski S; Doroszkiewicz W
    Pol Merkur Lekarski; 2003 Apr; 14(82):322-6. PubMed ID: 12868193
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Drug therapy. Beta-lactam antibiotics (2).
    Donowitz GR; Mandell GL
    N Engl J Med; 1988 Feb; 318(8):490-500. PubMed ID: 3277054
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.